Characterize Isentress® (raltegravir) - resistant viruses in patients with treatment failures.
Interpretive report provided. Includes drug resistance information for integrase inhibitors.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
- HIV-1 Phenosense Integrase
- PhenoSense Integrase Phenotypic Test
- HIV Phenotype, Raltegravir
- Human Immunodeficiency Virus Type 1 Raltegravir Phenotype
Test sent to Mayo Medical Laboratories; performed by Monogram Biosciences.